NOVO.B.DK

433.1

-0.21%↓

COLO.B.DK

602.6

-0.13%↓

GMAB.DK

1,405.5

+3.16%↑

ZEAL.DK

364.5

-1%↓

AMBUB.DK

98

+0.72%↑

NOVO.B.DK

433.1

-0.21%↓

COLO.B.DK

602.6

-0.13%↓

GMAB.DK

1,405.5

+3.16%↑

ZEAL.DK

364.5

-1%↓

AMBUB.DK

98

+0.72%↑

NOVO.B.DK

433.1

-0.21%↓

COLO.B.DK

602.6

-0.13%↓

GMAB.DK

1,405.5

+3.16%↑

ZEAL.DK

364.5

-1%↓

AMBUB.DK

98

+0.72%↑

NOVO.B.DK

433.1

-0.21%↓

COLO.B.DK

602.6

-0.13%↓

GMAB.DK

1,405.5

+3.16%↑

ZEAL.DK

364.5

-1%↓

AMBUB.DK

98

+0.72%↑

NOVO.B.DK

433.1

-0.21%↓

COLO.B.DK

602.6

-0.13%↓

GMAB.DK

1,405.5

+3.16%↑

ZEAL.DK

364.5

-1%↓

AMBUB.DK

98

+0.72%↑

Search

H Lundbeck A-S

Fermé

34.34 0.64

Résumé

Variation du prix de l'action

24h

Actuel

Min

34.12

Max

34.62

Chiffres clés

By Trading Economics

Revenu

562M

1.2B

Ventes

694M

6.2B

P/E

Moyenne du Secteur

10.5

39.857

BPA

1.53

Rendement du dividende

2.61

Marge bénéficiaire

18.476

Employés

5,700

EBITDA

811M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.61%

2.42%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-2.6B

34B

Ouverture précédente

33.7

Clôture précédente

34.34

H Lundbeck A-S Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 juil. 2025, 23:41 UTC

Market Talk

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15 juil. 2025, 23:40 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15 juil. 2025, 23:05 UTC

Market Talk

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15 juil. 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 juil. 2025, 21:36 UTC

Market Talk

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15 juil. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15 juil. 2025, 20:50 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

15 juil. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 juil. 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

15 juil. 2025, 20:14 UTC

Acquisitions, Fusions, Rachats

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15 juil. 2025, 20:07 UTC

Résultats

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15 juil. 2025, 20:06 UTC

Market Talk

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15 juil. 2025, 19:54 UTC

Market Talk

Global Equities Roundup: Market Talk

15 juil. 2025, 19:54 UTC

Market Talk

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15 juil. 2025, 19:38 UTC

Market Talk

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15 juil. 2025, 19:09 UTC

Market Talk

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15 juil. 2025, 19:07 UTC

Market Talk

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15 juil. 2025, 19:03 UTC

Market Talk

Gold Slips as Big Buyers Pull Back -- Market Talk

15 juil. 2025, 18:32 UTC

Acquisitions, Fusions, Rachats

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 juil. 2025, 18:31 UTC

Acquisitions, Fusions, Rachats

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15 juil. 2025, 18:13 UTC

Market Talk

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15 juil. 2025, 17:40 UTC

Market Talk

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15 juil. 2025, 17:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 juil. 2025, 17:25 UTC

Acquisitions, Fusions, Rachats

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15 juil. 2025, 17:24 UTC

Market Talk

Dollar Gains Strength After Inflation Data -- Market Talk

15 juil. 2025, 16:49 UTC

Market Talk

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15 juil. 2025, 16:20 UTC

Market Talk
Résultats

Financial Services Roundup: Market Talk

15 juil. 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 juil. 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 juil. 2025, 15:42 UTC

Market Talk

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Comparaison

Variation de prix

H Lundbeck A-S prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos H Lundbeck A-S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.